Assessing the inclusion of frailty scores in either the methodology or results of clinical intervention trials of heart failure: A scoping review
Bewertung der Berücksichtigung von Frailty-Scores in Methodik oder Ergebnissen klinischer Interventionsstudien zur Herzinsuffizienz: Scoping-Review
PLOS One · 12.11.2026 · 21 (11) · e0358624
DOI: 10.1371/journal.pone.0358624 ↗Auf einen Blick
Das Scoping-Review zeigte 10 Studien zu Herzinsuffizienz-Interventionen mit Frailty-Erfassung. Die meisten Daten stammten aus nachträglichen Analysen; primäre Evidenz blieb begrenzt.
Fragestellung
Wie wurde Frailty in klinischen Interventionsstudien zur Herzinsuffizienz berücksichtigt, insbesondere bei der Stratifikation von Ergebnissen oder Anpassung von Therapien?
Methode
Scoping-Review; Suche in MEDLINE, Ovid Embase, Cochrane CENTRAL und ClinicalTrials.gov bis August 2025; eingeschlossen waren Interventionsstudien mit validierter Frailty-Erfassung.
Ergebnisse
10 Studien erfüllten die Kriterien. 7 waren post-hoc-Analysen von RCTs, 2 prädefinierte Analysen und 1 RCT. 9 nutzten den Rockwood cumulative deficit approach; die Parameter variierten.
Einschränkungen
Heterogenität der Frailty-Messung reduzierte die Sicherheit der Schlussfolgerungen; der Großteil der Evidenz war retrospektiv.
Schlussfolgerung der Autor:innen
Die Primärevidenz zu Herzinsuffizienz-Interventionen mit Frailty-Berücksichtigung ist begrenzt. Mehr Primärevidenz und eine standardisierte, ganzheitliche Frailty-Messung werden benötigt.
Kernaussagen
- 10 Studien mit Frailty-Berücksichtigung in Herzinsuffizienz-Interventionen
- Meist post-hoc-Analysen; nur 1 randomisierte kontrollierte Studie
- Frailty-Messung heterogen, meist Rockwood cumulative deficit approach
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Scoping Review in der Zeitschrift PLOS One, online erschienen am 12.11.2026. Verfasst von Murhaf Al-Shalabi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Ipswich Hospital, East Suffolk and North Essex NHS Foundation Trust, Ipswich, United Kingdom. Hauptthemen laut MEDLINE: Heart Failure, Frailty. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Herzinsuffizienz, Gerontologische Pflege
Abstract (Originalsprache)
Chronic heart failure is highly prevalent in older adults, in whom frailty is common and associated with poorer outcomes. Despite advances in guideline-directed medical therapy, concerns regarding tolerability and polypharmacy contribute to under-utilization in frail patients. This scoping review aimed to map the existing evidence on how clinical interventional trials of heart failure management have incorporated frailty, specifically, whether trials have (i) stratified outcomes according to frailty status and/or (ii) adjusted treatment strategies based on frailty. We searched MEDLINE, Ovid Embase, Cochrane CENTRAL and ClinicalTrials.gov for interventional trials of heart failure published up to August 2025 that incorporated frailty using validated assessment tools. Eligible studies stratified outcomes by frailty status and/or adjusted interventions based on frailty. Data were extracted and a narrative synthesis was conducted. Ten studies met the inclusion criteria. Seven were post-hoc analyses of randomized controlled trials, two were prespecified analyses, and one was a randomized controlled trial. Two studies evaluated exercise-based interventions, one on implantable cardioverter-defibrillators, and the remainder on pharmacological-based therapies. Nine studies used the Rockwood cumulative deficit approach to measure frailty, although the parameters used varied between studies. Available secondary analyses suggest preserved efficacy across frailty groups for most pharmacological interventions, whereas other modalities did not show convincing improvements in heart failure-specific outcomes among frail patients. Primary evidence of heart failure interventions incorporating frailty remains limited, with a large bulk of the evidence available being retrospective. Although several reported pharmacological interventions appear to have preserved efficacy across frailty levels, some of these therapies were not recommended in current guidelines, and heterogeneity in frailty measurement reduced the confidence of conclusions drawn. The gaps identified in this review highlight the need for further primary evidence that incorporates frailty, plus a standardized holistic method of measuring frailty in heart failure patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Ipswich Hospital, East Suffolk and North Essex NHS Foundation Trust, Ipswich, United Kingdom.
- Norwich Medical School, University of East Anglia, Norwich, United Kingdom.
- Norfolk and Norwich University Hospital, Norwich, United Kingdom.
ORCID-Profile: Martyn Patel
Zitieren
APA
Al-Shalabi, M., Nazar, N. A., & Patel, M. (2026). Assessing the inclusion of frailty scores in either the methodology or results of clinical intervention trials of heart failure: A scoping review. PLOS One, 21(11), e0358624. https://doi.org/10.1371/journal.pone.0358624
Vancouver
Al-Shalabi M, Nazar NA, Patel M. Assessing the inclusion of frailty scores in either the methodology or results of clinical intervention trials of heart failure: A scoping review. PLOS One. 2026;21(11):e0358624. doi:10.1371/journal.pone.0358624
BibTeX
@article{AlShalabi2026,
author = {Al-Shalabi, Murhaf and Nazar, Nafeesa Abdul and Patel, Martyn},
title = {Assessing the inclusion of frailty scores in either the methodology or results of clinical intervention trials of heart failure: A scoping review},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {11},
pages = {e0358624},
doi = {10.1371/journal.pone.0358624}
}
EUVIMED